Performance of EMBC Embecta | -44.8% in 12m

Compare EMBC with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare Embecta with its related Sector/Index XLV

Compare Embecta with its related Sector/Index XLV

Performance Duell EMBC vs XLV

TimeFrame EMBC XLV
1 Day 1.76% 0.19%
1 Week 1.90% 1.99%
1 Month 36.1% 5.30%
3 Months 2.10% 1.18%
6 Months -9.85% 14.31%
12 Months -44.8% 13.25%
YTD -23.4% 5.81%
Rel. Perf. 1m 2.68
Rel. Perf. 3m -3.06
Rel. Perf. 6m -2.32
Rel. Perf. 12m -7.83

Is Embecta a good stock to buy?

Neither. Based on ValueRay Fundamental Analyses, Embecta is currently (May 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 5.06 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EMBC as of May 2024 is 11.05. This means that EMBC is currently overvalued and has a potential downside of -23.53% (Sold with Premium).

Is EMBC a buy, sell or hold?

  • Strong Buy: 0
  • Buy: 0
  • Hold: 2
  • Sell: 1
  • Strong Sell: 1
Embecta has received a consensus analysts rating of 2.25. Therefor, it is recommend to sell EMBC.
Values above 0%: EMBC is performing better - Values below 0%: EMBC is underperforming

Compare EMBC with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 0.26% 29.13% -27.24% -73.13%
US NASDAQ 100 QQQ -0.06% 27.11% -25.91% -79.97%
US Dow Jones Industrial 30 DIA 0.51% 30.60% -24.63% -66.73%
German DAX 40 DBXD 2.14% 30.91% -27.01% -59.20%
UK FTSE 100 ISFU 0.36% 26.51% -26.09% -59.47%
Shanghai Shenzhen CSI 300 CSI 300 0.75% 31.33% -11.97% -37.54%
Hongkong Hang Seng HSI -0.25% 13.20% -13.54% -39.41%
Japan Nikkei 225 EXX7 0.84% 35.18% -21.63% -55.55%
India NIFTY 50 INDA -0.52% 32.86% -27.43% -74.64%
Brasil Bovespa EWZ 1.99% 32.77% -6.09% -57.53%

EMBC Embecta vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 0.71% 32.11% -27.03% -80.60%
Consumer Discretionary XLY 1.43% 30.79% -16.64% -63.65%
Consumer Staples XLP 0.85% 31.00% -24.17% -50.85%
Energy XLE 0.43% 36.07% -23.81% -68.18%
Financial XLF -0.09% 30.83% -31.78% -77.48%
Health Care XLV -0.09% 30.76% -24.16% -58.07%
Industrial XLI 1.76% 32.03% -29.18% -72.53%
Materials XLB 1.50% 32.47% -25.67% -64.42%
Real Estate XLRE -0.34% 28.03% -18.65% -55.68%
Technology XLK -0.67% 26.04% -24.51% -80.42%
Utilities XLU 0.40% 25.50% -28.41% -58.01%
Aerospace & Defense XAR 0.83% 27.70% -24.10% -69.25%
Biotech XBI 0.45% 25.98% -33.94% -51.65%
Homebuilder XHB 1.32% 29.06% -40.11% -95.67%
Retail XRT 2.38% 29.37% -29.95% -74.32%

EMBC Embecta vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO 0.80% 38.44% -16.31% -65.27%
Natural Gas UNG -8.44% 4.52% 10.43% -8.83%
Gold GLD -1.52% 34.87% -31.82% -66.61%
Silver SLV -9.69% 26.17% -43.88% -76.52%
Copper CPER -3.76% 25.06% -41.51% -80.84%

Returns of EMBC vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 0.75% 33.19% -12.73% -38.65%
iShares High Yield Corp. Bond HYG 1.38% 33.81% -16.30% -55.49%
Does Embecta outperform its market, is EMBC a Sector Leader?
No, over the last 12 months Embecta (EMBC) made -44.82%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 13.25%.
Over the last 3 months EMBC made 2.10%, while XLV made 1.18%.
Period EMBC XLV S&P 500
1 Month 36.06% 5.30% 6.93%
3 Months 2.10% 1.18% 6.91%
12 Months -44.82% 13.25% 28.31%